1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. Canada >
  5. Quebec >
  6. CiToxLAB Group Acquires AccelLAB

M&A Deal Summary

CiToxLAB Group Acquires AccelLAB

On November 7, 2016, CiToxLAB Group acquired life science company AccelLAB

Acquisition Highlights
  • This is CiToxLAB Group’s 1st transaction in the Life Science sector.
  • This is CiToxLAB Group’s 1st transaction in Canada.
  • This is CiToxLAB Group’s 1st transaction in Quebec.

M&A Deal Summary
Date 2016-11-07
Target AccelLAB
Sector Life Science
Buyer(s) CiToxLAB Group
Deal Type Add-on Acquisition
Advisor(s) PwC Corporate Finance (Financial)
McMillan
Mayer Brown (Legal)

Target

AccelLAB

Boisbriand, Quebec, Canada
AccelLAB, Inc. is a preclinical Contract Research Organization (CRO) dedicated to the medical devices and biotechnology industry.

Search 214,107 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

CiToxLAB Group

Cedex, France
Category Company
Founded 1969
Sector Life Science
Employees1,000
DESCRIPTION

CiToxLAB Group is a provider of non-clinical contract research organization (CRO), specializing in regulated safety assessment services, non-regulated discovery services, and medical device testing. CiToxLAB Group was founded in 1969 and is based in Cedex, France.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Add-on Acquisition M&A Deals 1 of 1
State: Quebec M&A 1 of 1
Country: Canada M&A 1 of 1
Year: 2016 M&A 1 of 1
Mergr

Solution for

Product

Company

Legal